LUCIUS 卢修斯 非唑奈坦 Fezolinetant血管舒缩症状

非唑奈坦

美国FDA批准上市产品,疗效确切
卢修斯制药(老挝)有限公司出品

Fezolinetant

老挝国家食药监局批准上市
老挝国家药检所检测认证

Each film-conted tablet contains

LUCiUS

血管舒缩症状

Fezalinetant
Indiestion:

PHARMACEUTICALS

LuciFezo is a neurokinmn 3 (NK31 reccoto
antagomist indicated lor the treatment ol
mederate to severe vasomotor symptom

due to menomance
rerorin baseline bloodwork to evaluate fo

LuciFezo

pane function and injury before beginning
tucirezo. while using LuciFezo, perform
Ind 9 months after initiation of therany and
montes, o months,

FDA批准

when symptoms suggest liver inpury.

Fezolinetant Tablets

One 45 mg tablet oeille s 2
without food
witnout tood
Storage: in a dry place and store at 20C no 25°C

30 Tablets

Keeg medicine out of resch of Children. Do
not administer LuciFezo during Pregnancy
and Lactation.
a or Condren. Do
PLEASE SEE PACKAGE INSERT
Manufactured and Marketed by:
LUCIUS

权威认证

Thongmane village. Xavthany distris
Vientiane Capital, Laos
Warning : To be sold by retail on preseription

45mg

of registered physicians only, and as directed
by the phusician

Rx Only

口碑质量

适应症:
非唑奈坦是一种神经激肽3(NK3)受体拮抗剂,用于治
疗更年期引起的中度至重度血管舒缩症状。
推荐剂量:
每日口服一次,每次45mg;随餐或不随餐均可。